This year’s roundup of bad behavior in the life sciences and new initiatives to prevent misconduct
The Scientist
Most Recent
Archaea packages DNA around histones in a similar way to eukaryotes, suggesting that fitting a large genome into a small space was not the original role of chromatin.
The poxvirus stockpiles genes when it needs to adapt.
A clinical trial suggesting the heart benefits of the controversial treatment draws criticism from the scientific community.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
Nominated as a write-in candidate as a protest against the anti-science incumbent, famed naturalist Charles Darwin won 4,000 congressional votes in a Georgia county.
The malaria vaccine under development by GSK and the PATH initiative only protects about one in three babies, though some researchers say those odds are better than nothing.
In Chapter 2, "Consequences and Evolution: The Cause That Works Backwards," author Susan M. Schneider places evolutionary theory in terms of the science of consequences.
A magnesium supplement thought to improve brain functioning gets a small clinical trial.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
